Stay updated on Nivolumab in Relapsed/Refractory DLBCL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T15:55:32.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    - Site revision updated from v3.4.1 to v3.4.2. No study content or user-facing details were changed.
    Difference
    0.0%
    Check dated 2026-02-12T15:22:37.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page.
    Difference
    0.0%
    Check dated 2026-02-05T11:01:25.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deleted: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-29T03:45:29.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The update adds a minor revision label v3.3.4 and removes the previous v3.3.3 label from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:52:08.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added an expanded Locations section listing study sites by region and country (e.g., multiple U.S. states and international locations) and updated the page revision to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T08:38:37.000Z thumbnail image

Stay in the know with updates to Nivolumab in Relapsed/Refractory DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page.